FDA to Slow Down Use of Adult Stem Cells
By Susan Brinkmann, OCDS
Staff Writer
One of the nation’s leading adult stem cell therapy organizations is warning the public that the Food and Drug Administration (FDA) is teaming up with the nation’s pharmaceutical industry to declare a person’s own stem cells to be a “drug” which can be regulated, thus slowing down the use of these therapies by requiring years of clinical trials before they can be used.
